« EMBL Chemical Biology: The ChEMBL Database |
Main
| Pfizer's New Leaf »
September 28, 2012
Elan's Discovery Efforts - What's Going On?
Posted by Derek
Elan announced not long ago that they were going to spin off their drug discovery efforts into a separate entity, Neotope. But I've also heard that they've recently let go a large number of people in their discovery effort, and I haven't heard any talk of them being Neotoped - does anyone know what's going on over there?
Comments (2)
+ TrackBacks (0) | Category: Business and Markets
POST A COMMENT
- RELATED ENTRIES
- › AstraZeneca's Move To Hot, Happening Cambridge
- › Stealing A Compound, To Set Up in China
- › Tecfidera's Price
- › Novartis Loses the Glivec Patent Fight in India
- › ChemBark Closing Down (Update: Not Really!)
- › Fake Journals - But They'd Like Real Money
- › Chemical Probes Versus Drugs
- › Two New Books
College chemistry, 1983
The 2002 Model
After 10 years of blogging. . .
1. xsfmedkmst on September 30, 2012 7:49 AM writes...
Elan is now simply a receptical for collecting its share of tysabri cash while awaiting a buyout. The company gave up on real discovery research years ago after having squandered its lead in AD research due to some short sighted decision making. It was only the research pact with J&J that kept any med chemistry alive there at all. Too much effort was redirected from small molecule drug discovery to CNS biologicals built on the (misplaced) hopes of the recently crashed AD antibody candidates. Neotope is the spun-off skeletal remains of the biologics efforts with some seed funding to get it started.
Permalink to Comment2. Kugelrohr on October 3, 2012 1:07 PM writes...
Thanks for the update xsfmedkms. All MedChem gone at Elan? Great, yet another company that managed to kill the goose that lays the golden eggs.
Permalink to Comment